Skip to main content

Closed

IRIX: IRIDEX Corporation Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+8.2% / yr

Operating margin-5.1%

ROIC-17.0%

Financially safe

Stretched

Debt / equity0.90×

Interest coverage0.0×

Current ratio1.92×

IRIDEX Corporation

IRIXNASDAQ Global Market·USD·Closed

IRIDEX Corporation

IRIXNASDAQ·USD·Closed

$0.82

−1.39%

$0.82

−$0.01 (1.39%)

52W Range

2thpctl

Volume

1.56×avg

Mkt Cap

14.27MUSD

P/E

-4.3TTM

Div Yield

–ann

52W Range

2thpctl

Volume

1.56×avg

Market Cap

14.27MUSD

P/E Ratio

-4.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings